Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
BioSenic financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
€0.1
2022-12-28
Market Capitalization
€6.2 M
2022-12-28
CreditSafe Score
?
Score changed on Jun 04, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| EUR | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 1.0M | 1.0M | |||||
| Gross profit | 5.1M | 3.3M | 4.2M | 312.0K | 316.0K | 545.0K | 3.1M |
| Gross profit margin, % | 507.9% | 420.8% | |||||
| Operating expense total | 16.0M | 13.6M | 21.4M | 1.2M | 2.6M | 7.3M | 5.0M |
| Depreciation and amortization | 580.0K | 881.0K | 159.0K | 13.0K | 46.0K | 14.6M | 3.3M |
| EBITDA | (10.9M) | (10.3M) | (17.2M) | (864.0K) | (2.3M) | (6.8M) | (1.9M) |
| EBITDA margin, % | -1087.0% | -1723.3% | |||||
| EBIT | (11.4M) | (11.2M) | (17.4M) | (877.0K) | (2.3M) | (21.4M) | (5.2M) |
| EBIT margin, % | -1145.0% | -1739.2% | |||||
| Interest income | 66.0K | 26.0K | 33.0K | 3.0K | 57.0K | 57.0K | |
| Interest expense | 2.6M | 739.0K | 845.0K | 107.0K | 741.0K | 6.0M | 2.2M |
| Pre tax profit | (14.0M) | (10.3M) | (18.2M) | (984.0K) | (3.1M) | (29.0M) | (6.7M) |
| Income tax expense | 131.0K | 38.0K | 99.0K | (7.0K) | |||
| Net Income | (14.1M) | (10.3M) | (18.3M) | (984.0K) | (3.1M) | (29.0M) | (6.7M) |